Uganda: Experts Urge Caution Over HIV Prevention Injection
Health experts in Uganda are advising users of the HIV-preventing injection Lenacapavir to continue using other prevention methods, noting it is not a vaccine. The government is working to manage high demand and ensure consistent supply for those at high risk.
Why it matters
Effective management of new HIV prevention tools is essential for public health goals in sub-Saharan Africa.
Kampala - Experts have urged those who already received their first injection of the twice-yearly HIV preventing drug Lenacapavir to consider using combination prevention options, warning that the game changer injection is not a vaccine.
The initial recipients of the drug that has since had a lot of demand countrywide are set to receive their second dose in October and Dr Vincent Bagambe, the Policy Planning and Strategic Manager at the Uganda AIDS Commission says for those who access it, they should be keen on receiving their next dose on the prescribed dates if they are to maintain optimal drug levels in their blood.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in